Atossa Therapeutics
ATOS
#9542
Rank
C$99.35 M
Marketcap
C$0.77
Share price
-5.83%
Change (1 day)
-37.78%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -C$42.34 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$34.72 Million, an increase over its 2023 earnings that were of -C$40.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$42.34 Million21.95%
2024 -C$34.72 Million-15.25%
2023 -C$40.97 Million11.62%
2022 -C$36.71 Million30.84%
2021 -C$28.06 Million15.58%
2020 -C$24.27 Million3.41%
2019 -C$23.47 Million51.16%
2018 -C$15.53 Million40.41%
2017 -C$11.06 Million27.54%
2016 -C$8.67 Million-47.49%
2015 -C$16.52 Million-17.25%
2014 -C$19.96 Million35.91%
2013 -C$14.69 Million112.3%
2012 -C$6.92 Million46.53%
2011 -C$4.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.10 B-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$1.75 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$1.81 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
C$56.74 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-C$0.15 Billion 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-C$10.68 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA